Cargando…

Analysis of Prognostic Factors and Design of Prognosis Model for Patients with Stage IV Gastric Cancer Following First-Line Palliative Chemotherapy

BACKGROUND: This study was to investigate the prognostic factors of patients with advanced gastric cancer and described a sample model to better differentiate the patients who could better benefit from palliative chemotherapy. PATIENTS AND METHODS: In this retrospective study, 112 gastric cancer pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Qiyin, Lan, Xi, Li, Ni, Yuan, Daozu, Zhang, Jiliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588669/ https://www.ncbi.nlm.nih.gov/pubmed/33122945 http://dx.doi.org/10.2147/CMAR.S263320

Ejemplares similares

Early prediction of response to palliative chemotherapy in patients with stage-IV gastric and esophageal cancer
por: Ma, Xiaoyuan, et al.
Publicado: (2023)

Development and validation of a prognostic index for efficacy evaluation and prognosis of first-line chemotherapy in stage III–IV lung squamous cell carcinoma
por: Song, Jiangdian, et al.
Publicado: (2019)

Prognostic significance of a systemic inflammatory response in patients receiving first-line palliative chemotherapy for recurred or metastatic gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2011)

Surgical Outcomes and Survival Prognostic Factors for Palliative Gastrectomies in Stage IV Resectable Gastric Cancer Outlet Obstruction Patients
por: Choi, Won Yong, et al.
Publicado: (2020)

Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy
por: Watanabe, Hayato, et al.
Publicado: (2021)

Negative lymph node count is a significant prognostic factor in patient with stage IV gastric cancer after palliative gastrectomy
por: Zhuo, Changhua, et al.
Publicado: (2017)

Clinical Implication of DNA Damage Response Genes in Advanced Gastric Cancer Stage IV and Recurrent Gastric Cancer Patients After Gastrectomy Treated Palliative Chemotherapy
por: Kim, Jeong Eun, et al.
Publicado: (2023)

Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy
por: Duan, Xiao-Peng, et al.
Publicado: (2023)

Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer
por: Kim, Jin Won, et al.
Publicado: (2019)

Correlation Between Hemoglobin Levels and the Prognosis of First-Line Chemotherapy in Patients with Advanced Gastric Cancer
por: Wei, Qing, et al.
Publicado: (2020)

Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population‐based study
por: Shi, Tao, et al.
Publicado: (2019)

Prealbumin-to-Globulin Ratio Can Predict the Chemotherapy Outcomes and Prognosis of Patients with Gastric Cancer Receiving First-Line Chemotherapy
por: Wang, Zhuo, et al.
Publicado: (2020)

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma
por: Yousaf, Nadia, et al.
Publicado: (2015)

Prognostic value of fibrinogen-to-albumin ratio in patients with gastric cancer receiving first-line chemotherapy
por: Zhang, Liqun, et al.
Publicado: (2020)

Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapy
por: Cameron, Silke, et al.
Publicado: (2009)

Efficacy of docetaxel plus ramucirumab as palliative second-line therapy following first-line chemotherapy plus immune-checkpoint-inhibitor combination treatment in patients with non-small cell lung cancer (NSCLC) UICC stage IV
por: Brueckl, Wolfgang M., et al.
Publicado: (2021)

Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
por: Beom, Seung-Hoon, et al.
Publicado: (2018)

Prognostic factors for renal function deterioration during palliative first-line chemotherapy for metastatic colorectal cancer: a retrospective study
por: Lim, Ah Reum, et al.
Publicado: (2022)

Prognostic Impact of Ectopic Fat Deposition within Psoas Muscle in Stage IV Gastric Cancer Patients Undergoing Systemic Chemotherapy
por: Ikegami, Takako, et al.
Publicado: (2022)

Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil
por: Matsunaga, Tomoyuki, et al.
Publicado: (2021)

Abdominal Visceral-to-Subcutaneous Fat Volume Ratio Predicts Survival and Response to First-Line Palliative Chemotherapy in Patients with Advanced Gastric Cancer
por: Aringhieri, Giacomo, et al.
Publicado: (2023)

Real-world evidence on first- and second-line palliative chemotherapy in advanced pancreatic cancer
por: Blomstrand, Hakon, et al.
Publicado: (2021)

Minimally invasive surgery is feasible after preoperative chemotherapy for stage IV gastric cancer
por: Yamamoto, Kazuyoshi, et al.
Publicado: (2020)

Advantages of ypTNM Staging in Post-surgical Prognosis for Initially Unresectable or Stage IV Gastric Cancers
por: Jeong, Gyu-Seong, et al.
Publicado: (2020)

Controlling Nutritional Status (CONUT) score is a prognostic marker in III-IV NSCLC patients receiving first-line chemotherapy
por: Zhang, Yi, et al.
Publicado: (2023)

New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy
por: Koo, Dong-Hoe, et al.
Publicado: (2021)

Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report
por: Fukuda, Kosuke, et al.
Publicado: (2022)

The Clinical Implication of Conversion Surgery in Patients with Stage IV Gastric Cancer Who Received Systemic Chemotherapy
por: Shin, Min-Kyue, et al.
Publicado: (2023)

Regional Chemotherapy Is a Valuable Second-Line Approach in Metastatic Esophageal Cancer after Failure to First-Line Palliative Treatment
por: Vashist, Yogesh, et al.
Publicado: (2022)

Conversion Surgery for Stage IV Gastric Cancer
por: Zhang, Fei, et al.
Publicado: (2019)

(125)I Seed Permanent Implantation as a Palliative Treatment for Stage III and IV Hypopharyngeal Carcinoma
por: Li, Lei, et al.
Publicado: (2016)

Combination versus single-agent as palliative chemotherapy for gastric cancer
por: Choi, Jin-Hyuk, et al.
Publicado: (2020)

Distal Gastrectomy for Symptomatic Stage IV Gastric Cancer Contributes to Prognosis with Acceptable Safety Compared to Gastrojejunostomy
por: Fujikuni, Nobuaki, et al.
Publicado: (2022)

CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors
por: Li, Jiazheng, et al.
Publicado: (2023)

Fatal Myelotoxicity Following Palliative Chemotherapy With Cisplatin and Gemcitabine in a Patient With Stage IV Cholangiocarcinoma Linked to Post Mortem Diagnosis of Fanconi Anemia
por: Engel, Nils W., et al.
Publicado: (2019)

Reduced Dose Intensity FOLFOX-4 as First Line Palliative Chemotherapy in Elderly Patients with Advanced Colorectal Cancer
por: Kim, Jee Hyun, et al.
Publicado: (2005)

A Prognostic Model in Metastatic or Recurrent Gastric Cancer Patients with Good Performance Status Who Received First-Line Chemotherapy()
por: Wang, Jin, et al.
Publicado: (2016)

Blood neutrophil-lymphocyte ratio predicts survival for stages III-IV gastric cancer treated with neoadjuvant chemotherapy
por: Jin, Hailong, et al.
Publicado: (2013)

Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery
por: Ren, Xiangqing, et al.
Publicado: (2023)

Paclitaxel combined with capecitabine as first-line chemotherapy for advanced or recurrent gastric cancer
por: YUAN, MEIQIN, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fklrmbsd06eli79cb888csf7am